1. Aucubin has anti-inflammatory, anti-microbial, anti-algesic as well as anti-tumor activities.
2. Aucubin prevents neuronal death in the hippocampal CA1 region in rats with diabetic encephalopathy, it also has protective effects on H2O2-induced apoptosis in PC12 cells.
3. Aucubin may improve obesity-induced atherosclerosis by attenuating TNF-α-induced inflammatory responses.
4. Aucubin may be a potential therapeutic choice in the treatment of OA due to its anti-inflammatory and chondroprotective features.
5. Aucubin has antioxidant and pancreas-protective effect on rats with streptozotocin- induced diabetes, it may have value as a safe preventive or therapeutic agent against diabetes mellitus.
6. Aucubin may play an important role in the cellular defense mechanism against UV radiation-induced photoaging, via its antioxidant properties.
7. Aucubin shows high liver-protective activity against carbon tetrachloride/alpha-amanitin-induced hepatic damage in mice.
8. Aucubin suppresses hepatitis B viral DNA replication in vitro, conversion of aucubin to its aglycone form appeared to be a prerequisite step for an exhibition of such antiviral activity.
9. Aucubin and geniposidic acid in Eucommia ulmoides Oliver leaves have promoting effects on collagen synthesis.
10. Aucubin has antispasmodic activity, it antagonizes the uterine muscular contractions induced by acetylcholine and calcium, in a similar way to papaverine.
1. Dihydroresveratrol has antiproliferative activity against human prostate cancer PC3 cell line in vitro.
2. Dihydroresveratrol has inhibition in pancreatic oxidative damage, it has therapeutic potential for the management of acute pancreatitis, particularly for patients unresponsive to trans-resveratrol due to the lack of proper microbial strains.
3. Dihydroresveratrol can ameliorate acute pancreatitis-associated lung injury via an inhibitory modulation of pro-inflammatory response, which is associated with a suppression of the NF-κB signaling pathway.